AU2023092A - New hiv-1 gag and env peptides, diagnostic - Google Patents

New hiv-1 gag and env peptides, diagnostic

Info

Publication number
AU2023092A
AU2023092A AU20230/92A AU2023092A AU2023092A AU 2023092 A AU2023092 A AU 2023092A AU 20230/92 A AU20230/92 A AU 20230/92A AU 2023092 A AU2023092 A AU 2023092A AU 2023092 A AU2023092 A AU 2023092A
Authority
AU
Australia
Prior art keywords
gag
diagnostic
new hiv
env peptides
env
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU20230/92A
Inventor
Jonas Blomberg
Rudiger Pipkorn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Replico Medical AB
Original Assignee
Replico Medical AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Replico Medical AB filed Critical Replico Medical AB
Publication of AU2023092A publication Critical patent/AU2023092A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
AU20230/92A 1991-06-13 1992-06-15 New hiv-1 gag and env peptides, diagnostic Abandoned AU2023092A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9101863A SE9101863D0 (en) 1991-06-13 1991-06-13 PEPTIDES, DIAGNOSTIC ANTIGEN, VACCINE COMPOSITION AND PROCEDURES FOR SELECTING HIV STARMS
SE9101863 1991-06-13

Publications (1)

Publication Number Publication Date
AU2023092A true AU2023092A (en) 1993-01-12

Family

ID=20383068

Family Applications (1)

Application Number Title Priority Date Filing Date
AU20230/92A Abandoned AU2023092A (en) 1991-06-13 1992-06-15 New hiv-1 gag and env peptides, diagnostic

Country Status (3)

Country Link
AU (1) AU2023092A (en)
SE (1) SE9101863D0 (en)
WO (1) WO1992022572A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2290293A (en) * 1994-06-08 1995-12-20 Rupert Donald Holms Preparation which inhibits the autoimmune response in HIV, or SLE, patients
NO314588B1 (en) * 2000-09-04 2003-04-14 Bionor Immuno As HIV peptides, antigens, vaccine composition, immunoassay test kits and a method for detecting antibodies induced by HIV
ZA200407246B (en) * 2003-09-11 2005-06-29 Victor Anomah Ngu A vaccine
WO2007039458A2 (en) * 2005-09-21 2007-04-12 Cytos Biotechnology Ag Hiv peptide conjugates and uses thereof
EP1855112A1 (en) * 2006-05-10 2007-11-14 Inserm Method for the in vitro screening of compounds inhibiting production of infectious HIV-1 virions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5075211A (en) * 1986-03-26 1991-12-24 Genetic Systems Corporation Synthetic antigen for the detection of AIDS-related disease
CA1339363C (en) * 1987-05-01 1997-08-26 Alan Ray Flesher Monoclonal antibodies to specific antigenic regions of the human immunodeficiency virus and methods for use
ZA903492B (en) * 1989-05-15 1991-02-27 Akzo Nv T-lymphotropic retrovirus monoclonal antibodies
SE468168B (en) * 1990-02-20 1992-11-16 Replico Medical Ab HIV-1, P24 PEPTIDES, DIAGNOSTIC ANTIGENS AND PROCEDURES FOR DIFFERENTIAL DIAGNOSTICS OF PRELIMINARY HIV-1 POSITIVE SERUM TESTS

Also Published As

Publication number Publication date
WO1992022572A1 (en) 1992-12-23
SE9101863D0 (en) 1991-06-13

Similar Documents

Publication Publication Date Title
EP0676954A4 (en) Human immunodeficiency virus decoy.
HU896283D0 (en) Colon-selective, peroral medical preparation
AU4403689A (en) Hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids
AU617088B2 (en) Peptides involved in the pathogenesis of hiv infection
AU7060896A (en) Substituted sulfonimidamides, processes for their preparation, their use as a medicament or diagnostic, and medicament comprising them
AU3063389A (en) Hiv-2-type retroviruses of primates, vaccines, diagnostic and pharmaceutical compositions
AU6075190A (en) Retrovirus detection
IL90209A0 (en) Dna coding for a hiv-1 protein,the protein produced and its use
EP0853662A4 (en) Novel replication competent human immunodeficiency virus type 2 (hiv-2) proviral clone designated hiv-2kr
EP0611822A3 (en) More complex type retroviruses having mixed type LTR, and uses thereof.
AU4954596A (en) Recombinant human immunodeficiency virus-producing cell
AU7444891A (en) New hiv p24 peptides, diagnostic antigens and discriminative immunoassay method
AU2364597A (en) Substituted 2-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
AU3036997A (en) Use of chemokine antagonist molecules for their antiviral activity, particularly against an hiv type retrovirus
EP0437729A3 (en) New peptides, procedure for their preparation and their use as a medicament, especially their use as medicament against retroviruses
AU2023092A (en) New hiv-1 gag and env peptides, diagnostic
AU7495796A (en) Novel oligopeptides, the preparation and use thereof
AU3557889A (en) Protective peptides derived from human immunodeficiency virus-1 gp160
AU6161794A (en) Peptides having anti-hiv activity
AU2530795A (en) Assay for hiv-1 group o using at least one gp41 peptide
AU5836390A (en) Human lymphoma-associated virus
AU604793B2 (en) Env/gag-polypeptides
AU7244094A (en) Lavendamycin analogs, their use and preparation
EP0472078A3 (en) Phosphonopyrrolidin- and piperidin-containing statin-type pseudopeptides, their preparation and use against retroviruses
AU7289587A (en) Immunosuppressive factor from human immunodeficiency virus (hiv) or hiv infected cells or cell lines, its use, corresponding antibodies and their use